| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-10 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.29 | 5e-09 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-07 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-07 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.18 | 5e-07 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |